209. The effect of plasma transfusion on morbidity and mortality: a systemic review and meta-analysis 
(Transfusion 2010)

208. Duration of red cell storage and survival  of transfused patients
(Transfusion 2010)

207. Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty
(Vox Sanguinis, 2010)

206. Appropriateness of fresh-frozen plasma usage in hospital settings: a meta-analysis of the impact of organizational interventions
(Transfusion 2010)

205. Frequency and severity of transfusion-related acute lung injury – German haemovigilance data (2006-2007)
(Vox Sanguinis, 2010)

204. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks
(Transfusion 2009) 

203. Maintenance of in vitro properties of leucoreduced whole blood-derived pooled platelets after a 24-hour interruption of agitation
(Transfusion, 2009)

202. The German Haemovigilance System – reports of serious adverse transfusion reactions
between 1997 and 2007
(Transfusion Medicine, 2009)

201. Bacterial screening of platelet concentrates: results of 2 years active surveillance of transfused positive cultured units released as negative to date
(Vox Sanguinis 2009)

200. How do we provide blood products to trauma patients?
(Transfusion Medicine, 2009)

199. Association between duration of storage of transfused red blood cells and morbidity in adult patients:
(Transfusion, 2009)

198. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
(Transfusion, 2009)

197. Rapid thawing of fresh-frozen plasma with radio wave-based thawing technology and effects on coagulation factors during prolonged storage at 4° C
(Vox Sanguinis 2009)

196. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based metaanalysis of cohort studies
(Transfusion, 2009)

195. Recombinant activated factor VII in the treatment of non-haemophilia patients: physician under-reporting of thrombolic adverse events
(Transfusion Medicine, 2009)

194. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience
(Transfusion Medicine, 2009)

193. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donors
(Transfusion, 2009)

192. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs
(Transfusion, 2009)

191. Enhancend detection of blood bank sample collection errors with a centralized patient database
(Transfusion, 2009)

190. Red blood cell antibody frequency, specifity and properties in a population of male military veterans
(Transfusion 2008)

189. How much residual plasma may cause TRALI?
(Transfusion Medicine 2008)

188. Cold storage of pooled, buffy-coat-derived, leucoreduced platelets in plasma
(Vox Sang 2008)

187. Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis
(Transfusion 2008)

186. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry
(Transfusion 2008)

185. Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiply injuriy: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie
(Vox Sang 2008)

184. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review
(Transfusion 2008)

183. Prospective evaluation of a transfusion policy of D+ red blood cells into D-patients
(Transfusion 2008)

182. The ongoing variability in blood transfusion practices in cardiac surgery
(Transfusion 2007)

181. How often should a red blood cell administration set be changed while a patient is being transfused? A commentary and review of the literature
(Transfusion Medicine 2008)

180. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies
(Vox Sang 2008)

179. Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant
(N Engl J Med. 2008)

178. The influence of baseline haemoglobin concentration on tolerance of anemia in cardiac surgery
(Transfusion 2008)

177. Duration of Red-Cell Storage and Complications after Cardiac Surgery
(N Engl J Med. 2008)

176. Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006
(Transfusion 2008)

175. Blood transfusions in children: a multi-institutional analysis of practices and complications
(Transfusion 2008)

174. Why don´t women volunteer to give blood? A study of knowledge, attitude and practice of women about blood donation, Yazd, Iran 2005(Transfusion 2007)

173. Patient-specific transfusion-related acute lung injury
(Vox Sanguinis 2008)

172. Clinical predictors of alloimmunization after red blood cell transfusion
(Transfusion 2007)

171. Detection of anti-D in D- recipients transfused with D+ red blood cells
(Transfusion 2007)

170. Effect of gamma irradiation with 30 Gy on the coagulation system in leucore-duced fresh-frozen plasma
(Transfusion 2007)

169. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies
(Vox Sanguinis 2007)

168. AABB survey of transfusion-related acute lung injury policies and practices in the United States
(Transfusion 2007)

167. Profound thrombocytopenia and survival of hematopoetic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 109 or 20 x 109 per L
(Transfusion 2007)

166. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature
(Transfusion 2007)

165. Blood use in elective surgery: the Austrian benchmark study
(Transfusion 2007)

164. Increase in recently acquired syphilis infections in English, Welsh and Northern Irish blood donors
(Vox Sanguinis 2007)

163. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures
(Transfusion 2007)

162. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy
(Vox Sanguinis 2007)

161. Risk of cancer after blood transfusion from donors with subclinical cancer: a ret-rospective cohort study
(The Lancet 2007)

160. Management and outcome of 200 cases of fetometernal alloimmune thrombocytopenia
(Transfusion 2007)

159. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross
(Transfusion 2007)

158. Bacterial contamination of platelets concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets
(Transfusion 2007)

157. Documenting a transfusion: how well is it done?
(Transfusion 2007)

156. Seven hundred and fifty-nine (759) chances to learn: a 3-year pilot project to analyse transfusion-related near-miss events in the Republic of Ireland
(Vox Sanguinis 2007)

155. How I do it: platelet support for refractory patients
(Transfusion 2007)

154. Platelet utilization and the transfusion trigger: a prospective analysis
(Transfusion 2007)

153. Haematological malignancies developing in previously healthy individuals who received haematopoetic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR)
(British Journal of Haematology 2006)

152. Acute transfusion reactions in the pediatric intensive care unit [Transfusion 2006]

151. Empfehlungen zur Thrombozytensubstitution der Thrombozyten-Arbeitsgruppe der DGTI, GFH und DGHO
[Transfus Med Haemother 2006]

150. Transfusion audit of fresh-frozen plasma in southern Taiwan
[Vox Sang 2006]

149. Population-based audit of fresh frozen plasma transfusion practices
[Transfusion 2006]

148. An audit of red cells and blood product use after the institution of thrombelastometry in a cardiac intensive care unit
[Transfusion Medicine 2006]

147. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative
[Transfusion 2006]

146. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects
[Vox Sang 2006]

145. Are quality differences responsible for different adverse reactions reported for SD-plasma form USA and Europe?
[Transfusion Medicine 2005]

144. Efficicay of single-dose pegfilgrastrim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma
[Transfusion 2006]

143. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities
[Transfusion 2006]

142. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells
[Transfusion 2006]

141. Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases
[Transfusion 2006]

140. Anti-D alloimmunization after D-missmatched allogenic hematopoetic stem cell transplantation in patients with hematologic dieseases [Transfusion 2006]

139. Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT) [Blood 2006]

138. Effects of skin desinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands [Transfusion 2006]

137. Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany [Vox Sang 2006]

136. High-dose Antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety [Crit Care Med 2006]

135. The Risk Associated with Aprotinin in Cardiac Surgery [N Engl J Med 2006]

134. Consenting to blood: what do patients remember? [Transfusion Medicine 2005]

133. White blood cell-reactive antibodies are undectable in solvent/detergent plasma [Transfusion 2005]

132. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers [Transfusion 2006]

131.Venous and arterial thrombosis following administration of intravenous immunoglobulins [Blood Coagulation and Fibrinolysis 2005]

130. Infektionsepidemiologische Meldungen von Blutspendern [Epidemiologisches Bulletin 2005]

129. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis [Transfusion Medicine Reviews 2005]

128. Transfusion practice in massively bleeding patients: time for a change? [Vox Sanguinis 2005]

127. Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection
[Vox Sanguinis 2005]

126. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 109 per L versus 30 x 109 per L in allogenic hematopoetic progenitor cell transplant recipients
[Transfusion 2005]

125. The influence of human platelet antigen match on the success of allogenic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen
[Transfusion 2005]

124. Delayed platelet engraftment in group 0 patients after autologous progenitor cell transplantation
[Transfusion 2005]

123. Six years’ experience of using the BacT/ALERT system to screen all platelet concentrates,and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results
[Vox Sanguinis 2005]

122. Home blood transfusion: a necessary service development
[Transfusion 2005]

121. Rekombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case control analysis
[Transfusion 2005]

120. Streptococcus bovis Septic Shock Due to Contaminated Transfused Platelets
[American Journal of Hematology 2004]

119. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant und patients with acute leukaemia: a randomized controlled trial with a sequential Bayesian design
[Transfusion 2004]

118. Severe hemolysis resulting from D incompatibility in a case of ABO-identical liver transplant
[Transfusion 2004]

117. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study
[Transfusion 2004]

116. Bacterial contamination of cellular blood components: risks, sources and control
[Vox Sanguinis 2004]

115. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage
[Transfusion 2004]

114. Leucocytedepletion leads to component-like storage stability of whole blood - suggesting its homologous use?
[Vox Sanguinis 2004]

113. Acute lung injury after blood transfusion in mechanically ventilated patients
[Transfusion 2004]

112. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines
[Transfusion 2004]

111. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
[The Lancet 2004]

110. Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
[Transfusion Medicine 2004]

109. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes
[Transfusion 2004]

108. Recombinant activated factor VII (NovoSeven) addition to replacement therapy in acute, uncontrolled and life-threatening bleeding
[Vox Sanguinis 2004]

107. Improvement in fresh frozen plasma transfusion practice: results of an outcome audit
[Transfusion Medicine 2004]

106. Decreased platelet aggregation of platelet concentrate during storage recovers in the body after transfusion
[Transfusion 2004]

105. Blood transfusion rates in the care of acute trauma
[Transfusion 2004]

104. Analysis of ABO discrepancies occuring in 35 French hospitals
[Transfusion 2004]

103. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis
[Transfusion 2004]

102. Thrombotic Thrombocytopenic Purpura and Prgnancy: Report of Four Cases and Literature Review
[Journal of Clinical Apheresis 2004]

101. White blood cell-containing allogenic blood transfusion, postoperative infection and mortalitiy: a meta-analysis of observational “before-an-after” studies
[Vox Sanguinis 2004]

100. Preliminary validation of a new standard of efficacy for stored platelets[Transfusion 2004]

99. Oncological Mangement of Pediatric Cancer Patients Belonging to Jehovah’s Witnesses: A Two-Institutional Experience Report
[Onkologie 2004]

98. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
[The Lancet 2004]

97. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis
[Transfusion 2003]

96. Recombinant F VIIa in the management of uncontrolled hemorrhage
[Transfusion 2003]

95. Transfusion-associated GVHD after fludarabine therapy in a patient with systemic lupus erythematosus
[Transfusion 2003]

94. Transfusion-associated GVHD: 10 years`s experience at the American University of Beirut–Medical Center
[Transfusion 2003]

93. The impact of intensive serial plasmapheresis and iron supplementation on iron metabolism and Hb concentration in menstruating woman: a prospective randomized placebo-controlled double-blind study
[Transfusion 2003]

92. PLTs of Blood Group A1 donors express increased surface A antigen owing to apheresis and prolonged storage
[Transfusion 2003]

91. Seven-day storage of random donor PLT concentrates
[Transfusion 2003]

90. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers
[Ann Hematol 2004]

89. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial

88. Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture

87. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion

86. Single hospital experience of TRALI

85. Role of Splenectomy in Patients With Refractory or Relapsed Thrombotic Thrombocytopenic Purpura

84. An international study of the performance of sample collection from patients

83. WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization

82. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products

81. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study

80. Probability of anti-D development in D- patients receiving D+ RBCs

79. G-CSF-induced spleen size changes in peripheral blood progenitor cell donors

78. Effects of X-ray radiation on the rheologic properties of platelets and lymphocytes

77. Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin

76. Red cell transfusion practice following the transfusion requirements in critical care (TRICC) study: prospective observational cohort study in a large UK intensive care unit

75. Prenatal management of alloimmune thrombocytopenia of the fetus

74. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen incativation treatment: the euroSPRITE trial

73. Seven-day storage of apheresis platelets: report of an in vitro study

72. Absence of D-alloimmunization in AIDS patients receiving D-mismatched RBCs

71. An ABC for West Nile Virus

70. Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery

69. Which groups of patients are transfused? A study of red cell usage in London and southeast England

68. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998

67. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions

66. Blood collection and transfusion in the United States in 1997

65. Transfusion Triggers in the UK

64. Mad Cows and Englishmen: an Update on Blood and vCJD

63. Current trends in hematopoetic stem cell transplantation in Europe

62. Transfusion-related alloimmune neutropenia: an undescribed complication of blood transfusion

61. The risk of transfusion to the wrong patient in Germany

60. Viral marker rates among blood donors before and after the terrorist attacks on the United States on September 11, 2001

59. Estimated risk of transfusion-transmitted viral infections in Spain

58. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000

57. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy

56. Long-Term Treatment of Myasthenia Gravis with Immunoadsorption

55. Transfusion-Related Acute Lung Injury During Plasma Exchange: Suspecting the Unsuspected

54. Mortality and morbidity in patients with very low postoperative Hb levelswoh decline blood transfusions

53. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus

52. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections

51. Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?

50. A newly developed gel centrifugation test for quantification of RBC-bound IgG antibodies and their subclasses IgG1 and IgG3: comparison with flow cytometry

49. Artificial Oxygen Carriers–a Critical Analysis

48. Immunomodulation after Blood Transfusion – Impact on Incidence of Postoperative Infection

47. Use of recombinant factor VIIa to treat persistent bleeding following dental extractions in two cirrhotic patients

46. Acute haemolytic transfusion reactions due to weak antibodies that in vitro did not seem to be clinically relevant

45. Age at infection affects the long-term outcome of transfusion-associated chronic hepatis C

44. The risk of transfusion-acquired CMV infection in seronegative solid-organ transplant recipients receiving non-WBC-reduced blood components not screened for CMV antibody (1984 to 1996): experience at a single Canadian center

43. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients

42. Donor anti-Jka causing hemolysis in a liver transplant recipient

41. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens

40. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure

39. A pilot study to assess physician knowledge in transfusions medicine

38. Prospective evaluation of platelets prepared by single and random methods during 5 days of storage: aspects related to quality and quantity

37. Hemolytic anemia after kidney transplantation: case report and differential diagnosis

36. Multivariate analysis of determinants of bacterial contamination of whole-blood donations

35. Risk behavior in Norwegian blood donor

34. Transfusion transmitted bacterial infection in the United States, 1998 through 2000

33. Bacterial contamination of blood products: factors, options, and insights

32. Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery

31. High-Dose Antithrombin III in Severe Sepsis

30. Hemovigilance in Germany: Spontaneous Reported Suspected Cases of Transfusion Reactions to the Paul-Ehrlich-Institut between 01.01.1995 and 31.12.2000

29. Reporting of near-miss events for transfusion medicine: improving transfusion safety

28. The effect of hot beverages, cold beverages and chewing gum on oral temperature

27. A comparative study of the postoperative allogeneic blood-sparing effects of tranexamic acid and of desmopressin after total knee replacement

26. Advances in cardiac surgical transfusion practices during the 1990s in a Finnish university hospital

25. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions

24. Tissue distribution of protease resistant prion protein in variant Creutzfeld-Jakob disease using a high sensitve immunoblotting assay

23. Detection of variant Creutzfeld-Jakob disease infectivity in extraneural tissues

22. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions

21. Association of ABO-missmatched platelet transfusions with morbidity and mortality in cardiac surgery

20. The effect of external pressure, catheter gauge, and storage time on hemolysis in RBC transfusion

19. Preoperative autologous blood donation by elderly patients undergoing orthopaedic surgery

18. Red cell transfusions in neonatal care

17. Effect of gamma radiation on the vitro aggregability of WBC-reduced apheresis platelets

16. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

15. Transfusion-related acute lung injury after the infusion of IVIG

14. Risk behaviour among blood donors who give blood in order to be tested for the human immunodeficiency virus

13. Long-term survival in transfusion recipients in Sweden, 1993

12. Development of non-ABO RBC alloantibodies in patients undergoing allogenic HPC transplantation. Is ABO incompatibility a predisposing factor?

11. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treayted pooled plasma

10. Transfusion errors in New York State: an analysis of 10 years´ experience

9. Transmission of BSE by blood transfusion in sheep

8. A randomized trial comparing acute normovolemic hemodilution and preoperative autologous blood donation in total hip arthroplasty

7. RBC Antibody Persistance

6. Transfusion Thresholds in Common Elective Surgical Procedures in Finnland

5. RBC transfusion and postoperative length of stay in the hospital or the intensive care unit among patients undergoing coronry artery bypass graft surgery: the effects of confounding factors

4. Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection

3. Errors in Interpreting the Pretransfusion Bedside Compatibility Test

2. Epilepsy is not a contraindication for autologous blood donation

1. Acute intravascular hemolysis secondary to out-of group platelet transfusion